Very few meta-analyses or systematic reviews have investigated the effects of SGLT2 inhibitors on the risk of stroke in patients with T2DM, therefore a meta-analysis of all relevant published literature from RCTs was performed to qualitatively and quantitatively investigate the effects of SGLT2 inhibitors on the risk of stroke in diabetic individuals. The gene discussed is SLC5A2; the disease is stroke disorder.